In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
In Vitro Evaluation of a Soluble Leishmania Promastigote Surface Antigen as a Potential Vaccine Candidate against Human Leishmaniasis
Authors
Keywords
Immune response, Leishmania infantum, Leishmaniasis, Leishmania, Leishmania donovani, Vaccines, T cells, Promastigotes
Journal
PLoS One
Volume 9, Issue 5, Pages e92708
Publisher
Public Library of Science (PLoS)
Online
2014-05-03
DOI
10.1371/journal.pone.0092708
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- CD8+ Granzyme B+–Mediated Tissue Injury vs. CD4+IFNγ+–Mediated Parasite Killing in Human Cutaneous Leishmaniasis
- (2013) Claire da Silva Santos et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Evaluation of immune responses and analysis of the effect of vaccination of the Leishmania major recombinant ribosomal proteins L3 or L5 in two different murine models of cutaneous leishmaniasis
- (2013) Laura Ramírez et al. VACCINE
- Leishmaniasis Worldwide and Global Estimates of Its Incidence
- (2012) Jorge Alvar et al. PLoS One
- Granzyme B in injury, inflammation, and repair
- (2012) Paul R. Hiebert et al. TRENDS IN MOLECULAR MEDICINE
- Cytokine Responses to Novel Antigens in an Indian Population Living in an Area Endemic for Visceral Leishmaniasis
- (2012) Om Prakash Singh et al. PLoS Neglected Tropical Diseases
- T Helper1/T Helper2 Cells and Resistance/Susceptibility to Leishmania Infection: Is This Paradigm Still Relevant?
- (2012) James Alexander et al. Frontiers in Immunology
- Leishmaniasis impact and treatment access
- (2011) M. den Boer et al. CLINICAL MICROBIOLOGY AND INFECTION
- Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells
- (2011) Chiara F. Magnani et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Elongation Factor-2, a Th1 Stimulatory Protein of Leishmania donovani, Generates Strong IFN- and IL-12 Response in Cured Leishmania-Infected Patients/Hamsters and Protects Hamsters against Leishmania Challenge
- (2011) P. K. Kushawaha et al. JOURNAL OF IMMUNOLOGY
- Granzyme B-Dependent Proteolysis Acts as a Switch to Enhance the Proinflammatory Activity of IL-1α
- (2011) Inna S. Afonina et al. MOLECULAR CELL
- Visceral Leishmaniasis in the Indian Subcontinent: Modelling Epidemiology and Control
- (2011) Anette Stauch et al. PLoS Neglected Tropical Diseases
- IL-10 production by CD4+ effector T cells: a mechanism for self-regulation
- (2010) D Jankovic et al. Mucosal Immunology
- CD8 Cells of Patients with Diffuse Cutaneous Leishmaniasis Display Functional Exhaustion: The Latter Is Reversed, In Vitro, by TLR2 Agonists
- (2010) Joselín Hernández-Ruiz et al. PLoS Neglected Tropical Diseases
- Leishmania infantum sterol 24-c-methyltransferase formulated with MPL-SE induces cross-protection against L. major infection
- (2009) Yasuyuki Goto et al. VACCINE
- The promastigote surface antigen gene family of the Leishmania parasite: differential evolution by positive selection and recombination
- (2008) Alain Devault et al. BMC EVOLUTIONARY BIOLOGY
- Intradermal NKT cell activation during DNA priming in heterologous prime-boost vaccination enhances T cell responses and protection againstLeishmania
- (2008) Blaise Dondji et al. EUROPEAN JOURNAL OF IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started